Skip to content

AOCI at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
-$63.2M+67.0%
Veracyte logo
VeracyteVCYT
-$8.22M+71.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$70K-289%
NeoGenomics logo
NeoGenomicsNEO
$4K+107%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$4.54M+4.6%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$415K-353%

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$694.86M+29.9%
Enterprise value$667.82M+41.8%
P/S+0.5×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Castle Biosciences's AOCI?
Castle Biosciences (CSTL) reported AOCI of -$63K in Q1 2026.
How has Castle Biosciences's AOCI changed year-over-year?
Castle Biosciences's AOCI decreased by 148.1% year-over-year, from $131K to -$63K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.